Magnetic Resonance Imaging (MRI) Contrast Agents Market Report 2026

Magnetic Resonance Imaging (MRI) Contrast Agents Market Overview

• Magnetic Resonance Imaging (MRI) Contrast Agents market size has reached to $1.53 billion in 2025 • Expected to grow to $2.17 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Increasing Need For Accurate Diagnosis, Disease Monitoring, And Treatment Assessment • Market Trend: Advancing Safer And More Precise Brain Imaging With Innovative Iron-Based Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Magnetic Resonance Imaging (MRI) Contrast Agents Market?

Magnetic resonance imaging (MRI) contrast agents are substances that enhance the visibility of internal body structures during MRI scans by altering the local magnetic environment of tissues. They work primarily by affecting the relaxation times of nearby hydrogen nuclei, which changes the signal intensity on the resulting images. These agents improve the differentiation between normal and abnormal tissues, aiding in more accurate anatomical and pathological assessment. The main products of magnetic resonance imaging (MRI) contrast agents include super-paramagnetic agents and paramagnetic agents. Super-paramagnetic agents refer to contrast materials that enhance imaging by altering magnetic properties, improving visibility of specific tissues and structures during MRI procedures. These agents are administered through intravenous administration, oral administration, and intra articular administration. They find application in gastrointestinal, intravenous, hepato-biliary, neurological imaging, and other applications, serving end users including hospitals, diagnostic and imaging centres, research institutes, and other end-users.

What Is The Magnetic Resonance Imaging (MRI) Contrast Agents Market Growth Forecast?

The magnetic resonance imaging (MRI) contrast agents market size is expected to see strong growth in the next few years.It will grow to $2.17 billion by 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to development of targeted contrast agents, increasing demand for precision diagnostics, growth in outpatient imaging centers, technological innovation in contrast formulations, rising awareness of early disease detection.Major trends in the forecast period include increasing adoption of gadolinium-based contrast agents, growing demand for safer and low-toxicity agents, rising prevalence of neurological and gastrointestinal disorders, advancements in nanoparticle-based contrast agents, expanding use of mri in diagnostic imaging centers.

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Segmentation

1) By Product: Super-Paramagnetic Agents, Paramagnetic Agents 2) By Route Of Administration: Oral Administration, Intra Articular Administration 3) By Application: Gastrointestinal, Intravenous, Hepato-Biliary, Neurological Imaging, Other Applications 4) By End-Use: Hospitals, Diagnostic And Imaging Centres, Research Institutes, Other End-Users Subsegments: 1) By Super-Paramagnetic Agents: Iron Oxide Nanoparticles, Ultrasmall Superparamagnetic Iron Oxide Particles, Standard Superparamagnetic Iron Oxide Particles, Liver Targeted Superparamagnetic Agents 2) By Paramagnetic Agents: Gadolinium Based Contrast Agents, Manganese Based Contrast Agents, Macrocyclic Paramagnetic Agents, Linear Paramagnetic Agents

What Is The Driver Of The Magnetic Resonance Imaging (MRI) Contrast Agents Market?

The rising prevalence of chronic disease is expected to propel the growth of the magnetic resonance imaging (MRI) contrast agents industry going forward.A chronic disease is a long-lasting health condition that progresses slowly and usually persists for years.Chronic diseases are increasing due to unhealthy lifestyle habits such as poor diet and physical inactivity.Magnetic resonance imaging (MRI) contrast agents are used in chronic diseases to enhance visualization of tissues and abnormalities, enabling accurate diagnosis, monitoring of disease progression, and assessment of treatment response.For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK are living with cancer, a figure projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040.Therefore, the rising prevalence of chronic disease is driving the growth of the magnetic resonance imaging (MRI) contrast agents industry.

Key Players In The Global Magnetic Resonance Imaging (MRI) Contrast Agents Market

Major companies operating in the magnetic resonance imaging (mri) contrast agents market are Bayer AG, GE HealthCare Technologies Inc., Hengrui Medicine Co. Ltd., Zydus Lifesciences Ltd., Bracco Imaging S. p. A., Lantheus Holdings Inc., Guerbet SA, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Azurity Pharmaceuticals Inc., Yangtze River Pharmaceutical Group Co. Ltd., Beijing Beilu Pharmaceutical Co. Ltd., Unijules Life Sciences Ltd., Viwit Pharmaceutical Co. Ltd., Sanochemia Pharmazeutika AG, J. B. Chemicals & Pharmaceuticals Ltd., Nano Therapeutics Pvt. Ltd., Taejoon Pharm Co. Ltd., Nanoprobes Inc., Spago Nanomedical AB, Advanced Magnetics Inc

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Trends and Insights

Major companies operating in the magnetic resonance imaging (MRI) contrast agents market are focusing on developing innovative products such as, iron-based contrast agents to provide safer alternatives for patients with kidney issues and enhance imaging accuracy. Iron-based contrast agents are MRI agents containing superparamagnetic iron oxide nanoparticles that enhance image contrast by altering local magnetic fields, helping improve tumor and lesion visualization while offering a safer alternative for patients with kidney impairment. For instance, in February 2026, Azurity Pharmaceuticals, a U. S. -based pharmaceutical company, launched Ferabright, an iron-based contrast agent approved by the U. S. Food and Drug Administration (FDA) for MRI of the brain in adults with known or suspected malignant neoplasms. Ferabright is supplied in single-dose vials of 300 mg or 510 mg elemental iron per intravenous infusion, designed to improve visualization of brain lesions with disrupted blood-brain barriers. Its large molecular size allows it to remain intravascular during early imaging phases, and delayed-phase MRI highlights tumor enhancement through macrophage uptake. Additionally, Ferabright is processed via natural iron metabolism, reducing concerns about long-term retention and providing an alternative for patients who cannot receive gadolinium, while supporting environmentally sustainable imaging practices.

What Are Latest Mergers And Acquisitions In The Magnetic Resonance Imaging (MRI) Contrast Agents Market?

In March 2023, Bracco Imaging S. p. A., an Italy-based healthcare company specializing in diagnostic imaging agents, medical devices, and informatics solutions acquired the remaining 49% stake in Bracco-Eisai Co., Ltd. from Eisai Co., Ltd. for an undisclosed amount. Through this acquisition, Bracco Imaging aimed to gain full ownership of the joint venture, streamline its operations in Japan, and strengthen its diagnostic imaging business. Bracco-Eisai Co., Ltd. was a Japan-based pharmaceutical company. Involved in manufacturing and marketing MRI and CT contrast agents.

Regional Insights

North America was the largest region in the magnetic resonance imaging (MRI) contrast agents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Magnetic Resonance Imaging (MRI) Contrast Agents Market?

The magnetic resonance imaging (MRI) contrast agents market consists of sales of gadolinium-based contrast agents, iron oxide nanoparticles, manganese-based agents, and other paramagnetic or superparamagnetic imaging compounds. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Magnetic Resonance Imaging (MRI) Contrast Agents Industry?

The magnetic resonance imaging (mri) contrast agents market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the magnetic resonance imaging (mri) contrast agents industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Magnetic Resonance Imaging (MRI) Contrast Agents Market Report 2026?

The magnetic resonance imaging (MRI) contrast agents market research report is one of a series of new reports from The Business Research Company that provides magnetic resonance imaging (MRI) contrast agents market statistics, including magnetic resonance imaging (MRI) contrast agents industry global market size, regional shares, competitors with a magnetic resonance imaging (MRI) contrast agents market share, detailed magnetic resonance imaging (MRI) contrast agents market segments, market trends and opportunities, and any further data you may need to thrive in the magnetic resonance imaging (MRI) contrast agents industry. This magnetic resonance imaging (MRI) contrast agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.